Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
xjNthZfM0Hwn6a3R